Literature DB >> 30769001

Rho-inhibition and neuroprotective effect on rotenone-treated dopaminergic neurons in vitro.

Letizia Mattii1, Carla Pardini2, Chiara Ippolito3, Francesco Bianchi3, Antonietta Raffaella Maria Sabbatini4, Francesca Vaglini5.   

Abstract

Mesencephalic cell cultures are a good model to study the vulnerability of dopaminergic neurons and reproduce, in vitro, experimental models of Parkinson's disease. Rotenone associated as an environmental neurotoxin related to PD, is able to provoke dopaminergic neuron degeneration by inhibiting complex I of the mitochondrial respiratory chain and by inducing accumulation of α-synuclein. Recently, rotenone has been described to activate RhoA, a GTPase protein. In the present study we evaluated a possible neuroprotective effect of Rho-inhibitor molecules on rotenone-damaged dopaminergic (DA) neurons obtained from mouse primary mesencephalic cell culture. Our results showed that Clostridium Botulinum C3 toxin (C3) and simvastatin, as RhoA inhibitors, were able to protect DA neurons from rotenone damages. In fact, pretreatment with C3 or simvastatin significantly prevented the reduction of [3H]dopamine uptake, neurites injury and the expression patterns of proteins like α-syn, actin and connexin 43.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Connexin 43; Mesencephalic cell culture; RhoA; RhoA inhibitors; Rotenone; α-Synuclein

Year:  2019        PMID: 30769001     DOI: 10.1016/j.neuro.2019.02.006

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  2 in total

Review 1.  RhoA Signaling in Neurodegenerative Diseases.

Authors:  Sissel Ida Schmidt; Morten Blaabjerg; Kristine Freude; Morten Meyer
Journal:  Cells       Date:  2022-05-01       Impact factor: 7.666

Review 2.  Drug Repurposing for Parkinson's Disease: The International Linked Clinical Trials experience.

Authors:  Simon R W Stott; Richard K Wyse; Patrik Brundin
Journal:  Front Neurosci       Date:  2021-03-19       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.